- Home
- PET vs MIST Comparison
PET vs MIST Comparison
Compare PET & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- MIST
- Stock Information
- Founded
- PET 2015
- MIST 2003
- Country
- PET United States
- MIST Canada
- Employees
- PET N/A
- MIST N/A
- Industry
- PET EDP Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- PET Technology
- MIST Health Care
- Exchange
- PET Nasdaq
- MIST Nasdaq
- Market Cap
- PET 8.4M
- MIST 53.9M
- IPO Year
- PET N/A
- MIST N/A
- Fundamental
- Price
- PET $0.15
- MIST $1.12
- Analyst Decision
- PET Strong Buy
- MIST Strong Buy
- Analyst Count
- PET 5
- MIST 2
- Target Price
- PET $4.90
- MIST $9.50
- AVG Volume (30 Days)
- PET 11.3M
- MIST 1.6M
- Earning Date
- PET 05-12-2025
- MIST 05-20-2025
- Dividend Yield
- PET N/A
- MIST N/A
- EPS Growth
- PET N/A
- MIST N/A
- EPS
- PET N/A
- MIST N/A
- Revenue
- PET $70,507,000.00
- MIST N/A
- Revenue This Year
- PET $7.87
- MIST N/A
- Revenue Next Year
- PET $122.23
- MIST N/A
- P/E Ratio
- PET N/A
- MIST N/A
- Revenue Growth
- PET N/A
- MIST N/A
- 52 Week Low
- PET $0.08
- MIST $0.63
- 52 Week High
- PET $2.47
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- PET 47.48
- MIST 46.48
- Support Level
- PET $0.14
- MIST $1.28
- Resistance Level
- PET $0.16
- MIST $1.32
- Average True Range (ATR)
- PET 0.03
- MIST 0.12
- MACD
- PET 0.01
- MIST 0.03
- Stochastic Oscillator
- PET 49.63
- MIST 38.80
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).